Cardinal Health Inc vs McKesson Corporation — how do they compare? Cardinal Health Inc trades at $240.13 (market cap $55.88B), while McKesson Corporation trades at $899.7 (market cap $105.14B). The key difference: McKesson Corporation is the larger of the two by market cap, and Cardinal Health Inc pays the higher dividend (0.86%). Which is the better fit depends on your goals.
| CAH | MCK | |
|---|---|---|
Market Cap | $55.88B | $105.14B |
Sector | Health | Health |
52-Week High | $240.26 | $995.69 |
52-Week Low | $146.04 | $659.01 |
Enterprise Value | $59.91B | $111.67B |
Dividend Yield | 0.86% | 0.42% |
Trailing returns across standard periods
Latest headlines on both assets
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →